Nuclear Imaging Market By Diagnostic Technologies (PET Radioisotopes-(Rubidium-82, Fluorine-18, And Others), SPECT Radioisotopes-(Thallium-201, Technetium-99m, Xenon-133, Iodine-123, And Others)), By Application (PET-(Cardiology, Oncology, Neurology, And Others), SPECT-(Lymphoma, Neurology, Cardiology, Thyroid, And Others)) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Nuclear Imaging Market By Diagnostic Technologies (PET Radioisotopes-(Rubidium-82, Fluorine-18, And Others), SPECT Radioisotopes-(Thallium-201, Technetium-99m, Xenon-133, Iodine-123, And Others)), By Application (PET-(Cardiology, Oncology, Neurology, And Others), SPECT-(Lymphoma, Neurology, Cardiology, Thyroid, And Others)) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 1623 | Pages: 178 | November 2016 | Region: Global


The Global Nuclear Imaging Market was worth $10.03 billion in 2016 and estimated to be growing at a CAGR of 8.87%, to reach $15.34 billion by 2021. Nuclear imaging market is showing strong growth predominantly in the cardiac sector, amid the growing attention towards cardiac disease deterrence and treatment.

Nuclear imaging is generally utilized for cardiovascular and oncology applications. This technology allows doctors to formulate the appropriate alignment of radiation beams for the treatment of disease with sound accuracy. For instance, positron emission tomography (PET) imaging allows doctors to recognize chemical and physiologic variations in targeted tissues.

The growth of the Global Nuclear Imaging Market is mainly driven by factors such as an increasing utilization of SPECT and PET examination in radiopharmaceuticals, rise in cognizance for prompt diagnosis, increasing frequency of cardiac diseases, and improving healthcare infrastructure in this region. However, factors such as costly procedures & equipment, shortage of supplies, and logistical difficulties are hindering the growth of the market.

The Global Nuclear Imaging market is segmented based on Diagnostic Technologies and Application. The market for Nuclear Imaging, on the basis of Diagnostic Technologies is segmented into PET Radioisotopes and SPECT Radioisotopes. PET Radioisotopes are further segmented into Rubidium-82, Fluorine-18, whereas SPECT Radioisotopes are further segmented into Thallium-201, Technetium-99m, Xenon-133, and Iodine-123. On the basis of application, the global Nuclear Imaging market is segmented into PET and SPECT. PET is further segmented into Cardiology, Oncology, and Neurology, whereas SPECT is segmented into Lymphoma, Neurology, Cardiology, and Thyroid. PET is mainly being utilized in oncology due to superior quality of imaging; whereas SPECT used in the cardiology section accounts for almost 80% of the entire cardiology market share.

The market has also been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. U.S accounted for the largest share in the global Nuclear Imaging market in 2015, as it spends nearly 20% of its GDP on health. However, The Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as growing geriatric populace and surge in the chronic disease population.

Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution. The major companies dominating the global Nuclear Imaging market are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (Healthcare Division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.   

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Diagnostic Technologies        

                                5.1.1 Introduction

                                5.1.2 PET Radioisotopes

                                5.1.3 SPECT Radioisotopes

                                5.1.4 Y-o-Y Growth Analysis, By Diagnostic Technologies

                                5.1.5 Market Attractiveness Analysis, By Diagnostic Technologies

                                5.1.6 Market Share Analysis, By Diagnostic Technologies

                5.2 Application 

                                5.2.1 Introduction

                                5.2.2 PET

                                5.2.3 SPECT

                                5.2.4 Y-o-Y Growth Analysis, By Application

                                5.2.5 Market Attractiveness Analysis, By Application

                                5.2.6 Market Share Analysis, By Application

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                6.1.5 Market Share Analysis

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Mallinckrodt plc        

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Siemens Medical Solutions  

                8.3 Hitachi Medical Corporation

                8.4 Medtronic Inc.          

                8.5 General Electric Co. (healthcare division)       

                8.6 IBA Group   

                8.7 Positron Corporation              

                8.8 Philips Medical Systems        

                8.9 Naviscan      

                8.10 Toshiba Medical Systems Corporation          

                8.11 Carestream Health

                8.12 Lantheus Medical Imaging Inc.         

                8.13 Cardinal Health Inc.              

                8.14 Bayer AG  

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. Global Nuclear Imaging Market By Region, From 2016-2021 (USD Billion)
  2. Global Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  3. Global PET Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  4. Global Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  5. Global Rubidium-82 Market By Region, From 2016-2021 (USD Billion)
  6. Global Fluorine-18 Market By Region, From 2016-2021 (USD Billion)
  7. Global Other PET radioisotopes Market By Region, From 2016-2021 (USD Billion)
  8. Global SPECT Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  9. Global Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  10. Global Thallium-201 Market By Region, From 2016-2021 (USD Billion)
  11. Global Technetium-99m Market By Region, From 2016-2021 (USD Billion)
  12. Global Xenon-133 Market By Region, From 2016-2021 (USD Billion)
  13. Global Iodine-123 Market By Region, From 2016-2021 (USD Billion)
  14. Global Other SPECT radioisotopes Market By Region, From 2016-2021 (USD Billion)
  15. Global Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  16. Global PET Market By Region, From 2016-2021 (USD Billion)
  17. Global Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  18. Global Cardiology Market By Region, From 2016-2021 (USD Billion)
  19. Global Oncology Market By Region, From 2016-2021 (USD Billion)
  20. Global Neurology Market By Region, From 2016-2021 (USD Billion)
  21. Global Other PET applications Market By Region, From 2016-2021 (USD Billion)
  22. Global SPECT Market By Region, From 2016-2021 (USD Billion)
  23. Global Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  24. Global Lymphoma Market By Region, From 2016-2021 (USD Billion)
  25. Global Neurology Market By Region, From 2016-2021 (USD Billion)
  26. Global Cardiology Market By Region, From 2016-2021 (USD Billion)
  27. Global Thyroid Market By Region, From 2016-2021 (USD Billion)
  28. Global Other SPECT applications Market By Region, From 2016-2021 (USD Billion)
  29. North America Nuclear Imaging Market By Region, From 2016-2021 (USD Billion)
  30. North America Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  31. North America PET Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  32. North America Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  33. North America Rubidium-82 Market By Region, From 2016-2021 (USD Billion)
  34. North America Fluorine-18 Market By Region, From 2016-2021 (USD Billion)
  35. North America Other PET radioisotopes Market By Region, From 2016-2021 (USD Billion)
  36. North America SPECT Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  37. North America Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  38. North America Thallium-201 Market By Region, From 2016-2021 (USD Billion)
  39. North America Technetium-99m Market By Region, From 2016-2021 (USD Billion)
  40. North America Xenon-133 Market By Region, From 2016-2021 (USD Billion)
  41. North America Iodine-123 Market By Region, From 2016-2021 (USD Billion)
  42. North America Other SPECT radioisotopes Market By Region, From 2016-2021 (USD Billion)
  43. North America Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  44. North America PET Market By Region, From 2016-2021 (USD Billion)
  45. North America Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  46. North America Cardiology Market By Region, From 2016-2021 (USD Billion)
  47. North America Oncology Market By Region, From 2016-2021 (USD Billion)
  48. North America Neurology Market By Region, From 2016-2021 (USD Billion)
  49. North America Other PET applications Market By Region, From 2016-2021 (USD Billion)
  50. North America SPECT Market By Region, From 2016-2021 (USD Billion)
  51. North America Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  52. North America Lymphoma Market By Region, From 2016-2021 (USD Billion)
  53. North America Neurology Market By Region, From 2016-2021 (USD Billion)
  54. North America Cardiology Market By Region, From 2016-2021 (USD Billion)
  55. North America Thyroid Market By Region, From 2016-2021 (USD Billion)
  56. North America Other SPECT applications Market By Region, From 2016-2021 (USD Billion)
  57. United States Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  58. United States Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  59. United States Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  60. United States Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  61. United States Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  62. United States Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  63. Canada Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  64. Canada Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  65. Canada Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  66. Canada Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  67. Canada Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  68. Canada Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  69. Europe Nuclear Imaging Market By Region, From 2016-2021 (USD Billion)
  70. Europe Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  71. Europe PET Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  72. Europe Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  73. Europe Rubidium-82 Market By Region, From 2016-2021 (USD Billion)
  74. Europe Fluorine-18 Market By Region, From 2016-2021 (USD Billion)
  75. Europe Other PET radioisotopes Market By Region, From 2016-2021 (USD Billion)
  76. Europe SPECT Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  77. Europe Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  78. Europe Thallium-201 Market By Region, From 2016-2021 (USD Billion)
  79. Europe Technetium-99m Market By Region, From 2016-2021 (USD Billion)
  80. Europe Xenon-133 Market By Region, From 2016-2021 (USD Billion)
  81. Europe Iodine-123 Market By Region, From 2016-2021 (USD Billion)
  82. Europe Other SPECT radioisotopes Market By Region, From 2016-2021 (USD Billion)
  83. Europe Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  84. Europe PET Market By Region, From 2016-2021 (USD Billion)
  85. Europe Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  86. Europe Cardiology Market By Region, From 2016-2021 (USD Billion)
  87. Europe Oncology Market By Region, From 2016-2021 (USD Billion)
  88. Europe Neurology Market By Region, From 2016-2021 (USD Billion)
  89. Europe Other PET applications Market By Region, From 2016-2021 (USD Billion)
  90. Europe SPECT Market By Region, From 2016-2021 (USD Billion)
  91. Europe Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  92. Europe Lymphoma Market By Region, From 2016-2021 (USD Billion)
  93. Europe Neurology Market By Region, From 2016-2021 (USD Billion)
  94. Europe Cardiology Market By Region, From 2016-2021 (USD Billion)
  95. Europe Thyroid Market By Region, From 2016-2021 (USD Billion)
  96. Europe Other SPECT applications Market By Region, From 2016-2021 (USD Billion)
  97. U.K Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  98. U.K Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  99. U.K Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  100. U.K Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  101. U.K Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  102. U.K Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  103. Spain Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  104. Spain Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  105. Spain Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  106. Spain Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  107. Spain Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  108. Spain Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  109. Germany Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  110. Germany Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  111. Germany Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  112. Germany Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  113. Germany Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  114. Germany Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  115. Italy Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  116. Italy Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  117. Italy Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  118. Italy Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  119. Italy Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  120. Italy Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  121. France Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  122. France Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  123. France Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  124. France Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  125. France Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  126. France Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  127. Asia-Pacific Nuclear Imaging Market By Region, From 2016-2021 (USD Billion)
  128. Asia-Pacific Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  129. Asia-Pacific PET Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  130. Asia-Pacific Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  131. Asia-Pacific Rubidium-82 Market By Region, From 2016-2021 (USD Billion)
  132. Asia-Pacific Fluorine-18 Market By Region, From 2016-2021 (USD Billion)
  133. Asia-Pacific Other PET radioisotopes Market By Region, From 2016-2021 (USD Billion)
  134. Asia-Pacific SPECT Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  135. Asia-Pacific Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  136. Asia-Pacific Thallium-201 Market By Region, From 2016-2021 (USD Billion)
  137. Asia-Pacific Technetium-99m Market By Region, From 2016-2021 (USD Billion)
  138. Asia-Pacific Xenon-133 Market By Region, From 2016-2021 (USD Billion)
  139. Asia-Pacific Iodine-123 Market By Region, From 2016-2021 (USD Billion)
  140. Asia-Pacific Other SPECT radioisotopes Market By Region, From 2016-2021 (USD Billion)
  141. Asia-Pacific Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  142. Asia-Pacific PET Market By Region, From 2016-2021 (USD Billion)
  143. Asia-Pacific Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  144. Asia-Pacific Cardiology Market By Region, From 2016-2021 (USD Billion)
  145. Asia-Pacific Oncology Market By Region, From 2016-2021 (USD Billion)
  146. Asia-Pacific Neurology Market By Region, From 2016-2021 (USD Billion)
  147. Asia-Pacific Other PET applications Market By Region, From 2016-2021 (USD Billion)
  148. Asia-Pacific SPECT Market By Region, From 2016-2021 (USD Billion)
  149. Asia-Pacific Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  150. Asia-Pacific Lymphoma Market By Region, From 2016-2021 (USD Billion)
  151. Asia-Pacific Neurology Market By Region, From 2016-2021 (USD Billion)
  152. Asia-Pacific Cardiology Market By Region, From 2016-2021 (USD Billion)
  153. Asia-Pacific Thyroid Market By Region, From 2016-2021 (USD Billion)
  154. Asia-Pacific Other SPECT applications Market By Region, From 2016-2021 (USD Billion)
  155. China Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  156. China Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  157. China Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  158. China Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  159. China Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  160. China Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  161. India Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  162. India Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  163. India Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  164. India Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  165. India Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  166. India Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  167. Japan Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  168. Japan Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  169. Japan Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  170. Japan Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  171. Japan Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  172. Japan Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  173. South Korea Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  174. South Korea Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  175. South Korea Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  176. South Korea Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  177. South Korea Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  178. South Korea Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  179. Australia Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  180. Australia Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  181. Australia Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  182. Australia Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  183. Australia Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  184. Australia Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  185. Latin America Nuclear Imaging Market By Region, From 2016-2021 (USD Billion)
  186. Latin America Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  187. Latin America PET Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  188. Latin America Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  189. Latin America Rubidium-82 Market By Region, From 2016-2021 (USD Billion)
  190. Latin America Fluorine-18 Market By Region, From 2016-2021 (USD Billion)
  191. Latin America Other PET radioisotopes Market By Region, From 2016-2021 (USD Billion)
  192. Latin America SPECT Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  193. Latin America Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  194. Latin America Thallium-201 Market By Region, From 2016-2021 (USD Billion)
  195. Latin America Technetium-99m Market By Region, From 2016-2021 (USD Billion)
  196. Latin America Xenon-133 Market By Region, From 2016-2021 (USD Billion)
  197. Latin America Iodine-123 Market By Region, From 2016-2021 (USD Billion)
  198. Latin America Other SPECT radioisotopes Market By Region, From 2016-2021 (USD Billion)
  199. Latin America Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  200. Latin America PET Market By Region, From 2016-2021 (USD Billion)
  201. Latin America Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  202. Latin America Cardiology Market By Region, From 2016-2021 (USD Billion)
  203. Latin America Oncology Market By Region, From 2016-2021 (USD Billion)
  204. Latin America Neurology Market By Region, From 2016-2021 (USD Billion)
  205. Latin America Other PET applications Market By Region, From 2016-2021 (USD Billion)
  206. Latin America SPECT Market By Region, From 2016-2021 (USD Billion)
  207. Latin America Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  208. Latin America Lymphoma Market By Region, From 2016-2021 (USD Billion)
  209. Latin America Neurology Market By Region, From 2016-2021 (USD Billion)
  210. Latin America Cardiology Market By Region, From 2016-2021 (USD Billion)
  211. Latin America Thyroid Market By Region, From 2016-2021 (USD Billion)
  212. Latin America Other SPECT applications Market By Region, From 2016-2021 (USD Billion)
  213. Brazil Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  214. Brazil Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  215. Brazil Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  216. Brazil Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  217. Brazil Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  218. Brazil Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  219. Argentina Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  220. Argentina Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  221. Argentina Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  222. Argentina Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  223. Argentina Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  224. Argentina Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  225. Mexico Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  226. Mexico Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  227. Mexico Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  228. Mexico Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  229. Mexico Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  230. Mexico Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  231. Middle East & Africa Nuclear Imaging Market By Region, From 2016-2021 (USD Billion)
  232. Middle East & Africa Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  233. Middle East & Africa PET Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  234. Middle East & Africa Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  235. Middle East & Africa Rubidium-82 Market By Region, From 2016-2021 (USD Billion)
  236. Middle East & Africa Fluorine-18 Market By Region, From 2016-2021 (USD Billion)
  237. Middle East & Africa Other PET radioisotopes Market By Region, From 2016-2021 (USD Billion)
  238. Middle East & Africa SPECT Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  239. Middle East & Africa Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  240. Middle East & Africa Thallium-201 Market By Region, From 2016-2021 (USD Billion)
  241. Middle East & Africa Technetium-99m Market By Region, From 2016-2021 (USD Billion)
  242. Middle East & Africa Xenon-133 Market By Region, From 2016-2021 (USD Billion)
  243. Middle East & Africa Iodine-123 Market By Region, From 2016-2021 (USD Billion)
  244. Middle East & Africa Other SPECT radioisotopes Market By Region, From 2016-2021 (USD Billion)
  245. Middle East & Africa Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  246. Middle East & Africa PET Market By Region, From 2016-2021 (USD Billion)
  247. Middle East & Africa Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  248. Middle East & Africa Cardiology Market By Region, From 2016-2021 (USD Billion)
  249. Middle East & Africa Oncology Market By Region, From 2016-2021 (USD Billion)
  250. Middle East & Africa Neurology Market By Region, From 2016-2021 (USD Billion)
  251. Middle East & Africa Other PET applications Market By Region, From 2016-2021 (USD Billion)
  252. Middle East & Africa SPECT Market By Region, From 2016-2021 (USD Billion)
  253. Middle East & Africa Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  254. Middle East & Africa Lymphoma Market By Region, From 2016-2021 (USD Billion)
  255. Middle East & Africa Neurology Market By Region, From 2016-2021 (USD Billion)
  256. Middle East & Africa Cardiology Market By Region, From 2016-2021 (USD Billion)
  257. Middle East & Africa Thyroid Market By Region, From 2016-2021 (USD Billion)
  258. Middle East & Africa Other SPECT applications Market By Region, From 2016-2021 (USD Billion)
  259. Middle East Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  260. Middle East Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  261. Middle East Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  262. Middle East Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  263. Middle East Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  264. Middle East Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  265. Africa Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  266. Africa Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  267. Africa Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  268. Africa Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  269. Africa Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  270. Africa Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.